PepTek Research Library

This research comparison examines Selank vs NAD+ neuroprotection research, exploring their distinct molecular structures, mechanisms of action, and how investigators select between them in neuroscience studies.

IGF-1 LR3 vs CJC-1295 peptide research reveals two distinct growth-related pathways. This comparison covers structural differences, receptor mechanisms, and how researchers select between them.

SS-31 and glutathione represent two distinct antioxidant strategies in research: mitochondria-targeted vs. cytosolic defense. This comparison examines their structural differences, mechanisms, and research applications.

NAD+ and MOTS-C represent two distinct mitochondrial research targets with complementary roles in cellular energy regulation. This comparison explores their structures, mechanisms, and research applications.

GHRP-6 vs tesamorelin GH research reveals two distinct mechanistic pathways for stimulating growth hormone release, each suited to different experimental models and research objectives.

BPC-157 and GHK-Cu are two structurally distinct peptides studied for tissue repair mechanisms. This comparison examines their signaling pathways, research applications, and how investigators select between them.

SLU-PP-332 is a small-molecule ERR agonist studied for its ability to mimic metabolic adaptations of exercise in preclinical models. Research suggests it activates oxidative pathways in skeletal muscle and cardiac tissue.

A summary of the landmark retatrutide phase 2 trial research examining this triple GIP/GLP-1/glucagon receptor agonist, including key findings on metabolic and body weight outcomes in human subjects.

The SUSTAIN clinical trial program examined semaglutide cardiovascular research outcomes in subjects with type 2 diabetes, revealing significant reductions in major adverse cardiovascular events across multiple trial phases.

The SURPASS clinical trial program examined tirzepatide's dual GIP/GLP-1 receptor agonism across six large-scale trials, revealing significant findings in metabolic research models.

MOTS-c is a mitochondrial-derived peptide studied for its role in metabolic regulation, with research indicating effects on insulin sensitivity, AMPK activation, and glucose uptake in preclinical models.

GHRP-6 ghrelin receptor research studies reveal how this synthetic hexapeptide binds the GHS-R1a receptor to stimulate GH secretion and modulate downstream signaling pathways in preclinical models.

SS-31 cardiac ischemia research studies examine how this mitochondria-targeting peptide influences cardiomyocyte survival and oxidative stress during reperfusion injury in preclinical models.

Research into glutathione oxidative stress research reveals the tripeptide's central role in cellular redox homeostasis, ROS neutralization, and stress signaling across multiple experimental models.

IGF-1 LR3 muscle satellite cell research examines how this extended-half-life IGF-1 analogue activates quiescent satellite cells and drives myogenic proliferation in controlled laboratory models.

Semax cognitive performance research studies reveal consistent BDNF upregulation and neuroprotective signaling in preclinical models, making it a compelling subject for neuroscience investigation.

Research on melanotan II melanogenesis studies reveals how MT-2 activates MC1R to stimulate melanin synthesis in preclinical models, offering insights into pigmentation biology.

Research summaries examining selank GABA anxiety research studies reveal how this synthetic heptapeptide modulates GABAergic transmission in rodent anxiety models, offering insights into neuropeptide-based anxiolytic mechanisms.

Preclinical research on NAD+ mitochondrial function reveals critical roles in energy metabolism, sirtuin activation, and oxidative stress regulation across multiple animal and in vitro model systems.

Research into NAD+ sirtuins aging studies reveals how declining NAD+ levels impair sirtuin-mediated cellular repair, mitochondrial function, and genomic stability in aged organisms.

Tesamorelin visceral fat research studies demonstrate consistent reductions in visceral adipose tissue in controlled trials, offering researchers a valuable model for studying GHRH analogue effects on body composition.

Ipamorelin GH pulse research studies reveal how this selective GHRP stimulates pulsatile growth hormone release with high specificity. Key animal model findings are summarized here.

GHK-Cu antioxidant neuroprotection research highlights this copper-binding tripeptide's capacity to modulate oxidative stress pathways and support neuronal integrity in preclinical models.

GHK-Cu skin collagen research studies reveal significant upregulation of collagen synthesis pathways in fibroblast models. This summary reviews key published findings on the copper peptide's extracellular matrix activity.